Driving Skills at Licensure Can Predict Crashes Early in Licensure
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Oct. 16, 2023 -- Driving skills measured at the time of licensure can predict crashes early in licensure, according to a study published online Oct. 16 in Pediatrics.
Elizabeth A. Walshe, Ph.D., from the Children's Hospital of Philadelphia, and colleagues examined 16,914 young drivers (younger than 25 years) in Ohio who completed a virtual driving assessment and their subsequent police-reported crash records to examine how driving skills at licensure contribute to crash risk after licensure.
The researchers found that the crash risk was 10 percent lower than average for the best performing "No Issues" driving class, while the crash risk was 11 percent higher than average for the "Major Issues with Dangerous Behavior" class. After adjustment for covariates, including age, sex, and tract-level socioeconomic indicators, the results persisted. The crash risk was 16 percent higher than average for drivers licensed at age 18 years.
"These findings take us a step closer to identifying the drivers at risk of crashing early in licensure and some of the skills that are protective of future crashes," the authors write. "These results can inform targeted interventions that could be delivered at the time of licensure, providing actionable feedback or training to newly licensed drivers on areas needing continued improvement postlicensure."
Several authors disclosed ties to Diagnostic Driving Inc.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.